These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 15867227)
1. P16 loss and mitotic activity predict poor survival in patients with peritoneal malignant mesothelioma. Borczuk AC; Taub RN; Hesdorffer M; Hibshoosh H; Chabot JA; Keohan ML; Alsberry R; Alexis D; Powell CA Clin Cancer Res; 2005 May; 11(9):3303-8. PubMed ID: 15867227 [TBL] [Abstract][Full Text] [Related]
2. Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion. Deraco M; Nonaka D; Baratti D; Casali P; Rosai J; Younan R; Salvatore A; Cabras Ad AD; Kusamura S Ann Surg Oncol; 2006 Feb; 13(2):229-37. PubMed ID: 16444562 [TBL] [Abstract][Full Text] [Related]
3. Diffuse malignant mesothelioma of the peritoneum: a clinicopathological study of 35 patients treated locoregionally at a single institution. Nonaka D; Kusamura S; Baratti D; Casali P; Cabras AD; Younan R; Rosai J; Deraco M Cancer; 2005 Nov; 104(10):2181-8. PubMed ID: 16206294 [TBL] [Abstract][Full Text] [Related]
4. Significance of lymph node metastasis in patients with diffuse malignant peritoneal mesothelioma. Yan TD; Yoo D; Sugarbaker PH Eur J Surg Oncol; 2006 Nov; 32(9):948-53. PubMed ID: 16806796 [TBL] [Abstract][Full Text] [Related]
5. Prognostic indicators for patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma. Yan TD; Brun EA; Cerruto CA; Haveric N; Chang D; Sugarbaker PH Ann Surg Oncol; 2007 Jan; 14(1):41-9. PubMed ID: 17039392 [TBL] [Abstract][Full Text] [Related]
6. Diffuse malignant peritoneal mesothelioma: Failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC). Baratti D; Kusamura S; Cabras AD; Dileo P; Laterza B; Deraco M Ann Surg Oncol; 2009 Feb; 16(2):463-72. PubMed ID: 19082859 [TBL] [Abstract][Full Text] [Related]
7. Diffuse malignant epithelial mesotheliomas of the peritoneum in women: a clinicopathologic study of 25 patients. Kerrigan SA; Turnnir RT; Clement PB; Young RH; Churg A Cancer; 2002 Jan; 94(2):378-85. PubMed ID: 11905410 [TBL] [Abstract][Full Text] [Related]
8. High Wilms' tumour gene (WT1) expression and low mitotic count are independent predictors of survival in diffuse peritoneal mesothelioma. Scattone A; Serio G; Marzullo A; Nazzaro P; Corsi F; Cocca MP; Mattoni M; Punzi A; Gentile M; Buonadonna AL; Pennella A Histopathology; 2012 Feb; 60(3):472-81. PubMed ID: 22276610 [TBL] [Abstract][Full Text] [Related]
16. Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC). Baratti D; Kusamura S; Nonaka D; Oliva GD; Laterza B; Deraco M Ann Surg Oncol; 2007 Oct; 14(10):2790-7. PubMed ID: 17661150 [TBL] [Abstract][Full Text] [Related]
17. Morbidity, mortality, mean survival, and the impact of histology on survival after pleurectomy in 64 patients with malignant pleural mesothelioma. Neragi-Miandoab S; Richards WG; Sugarbaker DJ Int J Surg; 2008 Aug; 6(4):293-7. PubMed ID: 18585112 [TBL] [Abstract][Full Text] [Related]
18. Gene methylation in pleural mesothelioma: correlations with clinico-pathological features and patient's follow-up. Destro A; Ceresoli GL; Baryshnikova E; Garassino I; Zucali PA; De Vincenzo F; Bianchi P; Morenghi E; Testori A; Alloisio M; Santoro A; Roncalli M Lung Cancer; 2008 Mar; 59(3):369-76. PubMed ID: 17920725 [TBL] [Abstract][Full Text] [Related]